Rhaeos
Evanston, US · Founded 2018 · 3 known investors
Rhaeos develops FlowSense, a noninvasive wireless wearable skin patch that monitors fluid flow in the body, initially targeting hydrocephalus patients who depend on implantable shunts for cerebrospinal fluid management.
Founders & leadership
DC
Dr. Chad Webb
CS
Chad SeaverDirector
JA
John A. RogersExecutive Officer, Director
RC
R. Chad WebbExecutive Officer, Director
RG
Roozbeh GhaffariDirector
AL
Anna Lisa SomeraExecutive Officer
AZ
Adam ZyskExecutive Officer
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$6.2MraisedMar 2023 · 23 investors · Other Health CareRule 506(b)
▶$6.2MraisedMar 2023 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Chad SeaverDirector
- John A. RogersExecutive Officer, Director
- R. Chad WebbExecutive Officer, Director
- Roozbeh GhaffariDirector
- Anna Lisa SomeraExecutive Officer
- Adam ZyskExecutive Officer
- Offering amount
- $13M
- Amount sold
- $6.2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Rhaeos raises US$10.5 million in Series A funding to boost hydrocephalus productsneuronewsinternational.com · 2023
- Rhaeos Raises $10.5M in Series A Funding - FinSMEsfinsmes.com · 2023
- Rhaeos Raises $10.5M in Series A Funding to Launch Novel Hydrocephalus Shunt Monitor and Accelerate Pipeline Product Developmentprnewswire.com · 2023
- Rhaeos, Inc. Raises $2.2 Million in Oversubscribed Seed Roundprnewswire.com · 2021